| scholarly article | Q13442814 |
| P2093 | author name string | Bernard Rogister | |
| Sabine Wislet-Gendebien | |||
| Dorothée Cantinieaux | |||
| Rachelle Franzen | |||
| Cécile Coste | |||
| Virginie Neirinckx | |||
| P2860 | cites work | Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness | Q24650279 |
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Adult bone marrow stromal cells differentiate into neural cells in vitro | Q28142055 | ||
| Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
| Epidermal neural crest stem cells (EPI-NCSC) and pluripotency | Q28291240 | ||
| Biological activities encoded by the murine mesenchymal stem cell transcriptome provide a basis for their developmental potential and broad therapeutic efficacy | Q28507022 | ||
| Mesenchymal stem cells in health and disease | Q29614296 | ||
| Human adipose tissue is a source of multipotent stem cells | Q29617385 | ||
| Pluripotency of mesenchymal stem cells derived from adult marrow | Q29617959 | ||
| Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo | Q29618057 | ||
| Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells | Q29618766 | ||
| Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord | Q29619388 | ||
| Mesenchymal stem cells as trophic mediators | Q29619806 | ||
| Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord | Q30160386 | ||
| Mesenchymal progenitor cells in human umbilical cord blood | Q30168979 | ||
| Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury | Q30533831 | ||
| Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis | Q33228897 | ||
| BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury | Q33672421 | ||
| Bone marrow stromal stem cells: nature, biology, and potential applications | Q33947448 | ||
| A common neural progenitor for the CNS and PNS. | Q34067171 | ||
| SHED: stem cells from human exfoliated deciduous teeth. | Q34193093 | ||
| Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions | Q34321448 | ||
| Neural crest origin of olfactory ensheathing glia | Q34396998 | ||
| Plasticity of cultured mesenchymal stem cells: switch from nestin-positive to excitable neuron-like phenotype | Q34400430 | ||
| Aging effect on neurotrophic activity of human mesenchymal stem cells | Q34427950 | ||
| Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart | Q34454071 | ||
| Mesenchymal stem cells for the treatment of neurodegenerative disease. | Q34473474 | ||
| Isolation of multipotent neural crest-derived stem cells from the adult mouse cornea | Q34554237 | ||
| Antioxidant therapies for acute spinal cord injury | Q34627821 | ||
| Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. | Q34679913 | ||
| Comparison of functional and histological outcomes after intralesional, intracisternal, and intravenous transplantation of human bone marrow-derived mesenchymal stromal cells in a rat model of spinal cord injury | Q44463829 | ||
| Bone marrow-derived mesenchymal stem cell transplantation for chronic spinal cord injury in rats: comparative study between intralesional and intravenous transplantation | Q44543960 | ||
| Human mesenchymal stem cells isolated from olfactory biopsies but not bone enhance CNS myelination in vitro. | Q44572415 | ||
| Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury. | Q45920184 | ||
| Oligodendrogenesis of adult neural progenitors: differential effects of ciliary neurotrophic factor and mesenchymal stem cell derived factors | Q47351666 | ||
| Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study | Q47626218 | ||
| Neuronal apoptosis is inhibited by cord blood stem cells after spinal cord injury | Q47726002 | ||
| Comparison of mesenchymal stromal cells from human bone marrow and adipose tissue for the treatment of spinal cord injury | Q48179721 | ||
| Bone marrow stromal cells mediate protection through stimulation of PI3-K/Akt and MAPK signaling in neurons. | Q48393208 | ||
| Development of mesenchymal stem cells partially originate from the neural crest | Q50605496 | ||
| Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. | Q50639315 | ||
| Evidence supporting antioxidant action of adipose-derived stem cells: protection of human dermal fibroblasts from oxidative stress. | Q50911212 | ||
| Isolation and characterization of multipotent skin-derived precursors from human skin. | Q52048827 | ||
| Transplantation of an adipose stem cell cluster in a spinal cord injury. | Q53387591 | ||
| Involvement of mitochondrial signaling pathways in the mechanism of Fas-mediated apoptosis after spinal cord injury. | Q53426361 | ||
| Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. | Q53652498 | ||
| A dermal niche for multipotent adult skin-derived precursor cells. | Q54695107 | ||
| Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences | Q83473996 | ||
| Effect of neuroglobin genetically modified bone marrow mesenchymal stem cells transplantation on spinal cord injury in rabbits. | Q34713207 | ||
| Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application | Q34749244 | ||
| Adult bone marrow neural crest stem cells and mesenchymal stem cells are not able to replace lost neurons in acute MPTP-lesioned mice | Q34760743 | ||
| Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury | Q34801330 | ||
| A systematic review of cellular transplantation therapies for spinal cord injury | Q35127777 | ||
| The MSC: an injury drugstore | Q35130445 | ||
| Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation | Q35665181 | ||
| Neural crest stem cells: discovery, properties and potential for therapy | Q35732888 | ||
| Human umbilical cord blood-derived mesenchymal stem cell therapy promotes functional recovery of contused rat spinal cord through enhancement of endogenous cell proliferation and oligogenesis | Q35833322 | ||
| Human umbilical cord blood-derived mesenchymal stem cells undergo cellular senescence in response to oxidative stress | Q36093174 | ||
| Mesenchymal stem cells prime proliferating adult neural progenitors toward an oligodendrocyte fate | Q36093202 | ||
| An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury | Q36138503 | ||
| Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats | Q36157474 | ||
| Umbilical cord blood stem cell mediated downregulation of fas improves functional recovery of rats after spinal cord injury | Q36312720 | ||
| Advances in stem cell therapy for spinal cord injury | Q36357908 | ||
| Early Immunomodulation by Intravenously Transplanted Mesenchymal Stem Cells Promotes Functional Recovery in Spinal Cord Injured Rats | Q36680603 | ||
| Schwann cell coculture improves the therapeutic effect of bone marrow stromal cells on recovery in spinal cord-injured mice. | Q36858361 | ||
| Conditioned medium from bone marrow-derived mesenchymal stem cells improves recovery after spinal cord injury in rats: an original strategy to avoid cell transplantation | Q37125914 | ||
| Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury | Q37138010 | ||
| Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration. | Q37386259 | ||
| Progress and prospects: stem cells and neurological diseases | Q37794781 | ||
| Mesenchymal Stem Cells: Mechanisms of Inflammation | Q37809081 | ||
| Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases | Q37891375 | ||
| Concise review: Bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications | Q37898082 | ||
| Concise review: human pluripotent stem cells in the treatment of spinal cord injury | Q38021973 | ||
| Cell transplantation therapies for spinal cord injury focusing on induced pluripotent stem cells | Q38066391 | ||
| Mesenchymal cells in the treatment of spinal cord injury: current & future perspectives | Q38070021 | ||
| Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play | Q38088965 | ||
| Cell therapy with autologous mesenchymal stem cells-how the disease process impacts clinical considerations | Q38113315 | ||
| Characterization of the secretome of human tooth germ stem cells (hTGSCs) reveals neuro-protection by fine-tuning micro-environment | Q39177607 | ||
| Human mesenchymal stem cells efficiently manage oxidative stress | Q39716782 | ||
| Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells | Q40243228 | ||
| An epidermal neural crest stem cell (EPI-NCSC) molecular signature | Q40294384 | ||
| Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells | Q40317890 | ||
| Isolation of multipotent cells from human term placenta. | Q40457999 | ||
| Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo | Q40662801 | ||
| Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury | Q42089327 | ||
| Adult palatum as a novel source of neural crest-related stem cells. | Q42180952 | ||
| Neural crest-derived horizontal basal cells as tissue stem cells in the adult olfactory epithelium | Q42517743 | ||
| Mesenchymal stem cells promote oligodendroglial differentiation in hippocampal slice cultures | Q43285224 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 829-843 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | Stem Cells | Q15724411 |
| P1476 | title | Concise review: Spinal cord injuries: how could adult mesenchymal and neural crest stem cells take up the challenge? | |
| P478 | volume | 32 |
| Q39986776 | A Phase III Clinical Trial Showing Limited Efficacy of Autologous Mesenchymal Stem Cell Therapy for Spinal Cord Injury |
| Q34444848 | A nutrient mixture reduces the expression of matrix metalloproteinases in an animal model of spinal cord injury by modulating matrix metalloproteinase-2 and matrix metalloproteinase-9 promoter activities |
| Q36247199 | Adult bone marrow mesenchymal and neural crest stem cells are chemoattractive and accelerate motor recovery in a mouse model of spinal cord injury |
| Q30360306 | Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents. |
| Q35169874 | Biodegradable chitin conduit tubulation combined with bone marrow mesenchymal stem cell transplantation for treatment of spinal cord injury by reducing glial scar and cavity formation |
| Q38265206 | Cell-based therapy approaches: the hope for incurable diseases |
| Q48923684 | Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome |
| Q92457992 | Crosstalk between stem cell and spinal cord injury: pathophysiology and treatment strategies |
| Q28078431 | Current Concept of Stem Cell Therapy for Spinal Cord Injury: A Review |
| Q38304160 | Differences in the developmental origins of the periosteum may influence bone healing |
| Q42430208 | Dynamic expression of ATF3 as a novel tool to study activation and migration of endogenous spinal stem cells and their role in neural repair |
| Q41996326 | Engrafted peripheral blood-derived mesenchymal stem cells promote locomotive recovery in adult rats after spinal cord injury |
| Q37627069 | Gene Expression Profiling in the Injured Spinal Cord of Trachemys scripta elegans: An Amniote with Self-Repair Capabilities |
| Q33880485 | Human bone marrow harbors cells with neural crest-associated characteristics like human adipose and dermis tissues |
| Q58107623 | Laying the groundwork for a first-in-human study of an iPSC-based intervention for spinal cord injury |
| Q28072449 | Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches |
| Q49223227 | Mesenchymal Stem Cells Contribute to Improvement of Renal Function in a Canine Kidney Injury Model |
| Q92494488 | Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy |
| Q55082031 | Neural crest stem cells protect spinal cord neurons from excitotoxic damage and inhibit glial activation by secretion of brain-derived neurotrophic factor. |
| Q48058171 | New advances in understanding stem cell fate and function |
| Q52629289 | Rat vibrissa dermal papilla cells promote healing of spinal cord injury following transplantation. |
| Q92815648 | Stem Cells Therapy for Spinal Cord Injury: An Overview of Clinical Trials |
| Q38244902 | Stem cells in canine spinal cord injury--promise for regenerative therapy in a large animal model of human disease. |
| Q46046337 | Structural Analysis Provides Mechanistic Insight into Nicotine Oxidoreductase from Pseudomonas putida. |
| Q52669755 | The Biology of Regeneration Failure and Success After Spinal Cord Injury. |
| Q47987935 | Transplantation of human bone marrow-derived clonal mesenchymal stem cells reduces fibrotic scar formation in a rat spinal cord injury model |
| Q38875361 | Transplantation of human oligodendrocyte progenitor cells in an animal model of diffuse traumatic axonal injury: survival and differentiation |
| Q42363843 | Wogonoside alleviates inflammation induced by traumatic spinal cord injury by suppressing NF-κB and NLRP3 inflammasome activation |
Search more.